Iclusig 15 mg (Ponatinib (Ponatinib Hydrochloride) TABLET) 15 MG

ICLUSIG 15 MG tablets contain ponatinib hydrochloride, a medication used to treat certain types of cancer. This oral tablet is manufactured by Takeda Pharmaceuticals U.S.A., Inc. and is available in packs of 60 or 180 tablets.

Strength

15 MG

Pack Size

60/180

Manufacturer / TM Owner

TAKEDA PHARMACEUTICALS U.S.A., INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ICLUSIG 15 MG tablets are primarily used in the treatment of specific types of leukemia and other cancers. Ponatinib hydrochloride is a tyrosine kinase inhibitor, which works by targeting proteins that are involved in the growth and spread of cancer cells. This medication is often prescribed for patients who have not responded to other treatments or have a particular genetic marker associated with their cancer.

Side Effects

Common effects of ICLUSIG 15 MG tablets may include fatigue, rash, abdominal pain, and changes in blood cell counts. Some individuals may also experience nausea, dry skin, or headaches. It is important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

ICLUSIG 15 MG tablets should be handled with care and stored as directed. This medication may cause serious side effects, so it is important to follow the advice of a healthcare professional. Patients should inform their doctor about any other medications they are taking to avoid potential interactions.

Avoid Interactions

ICLUSIG 15 MG tablets may interact with other medications, including those that are metabolized by the liver. It is important to discuss all current medications with a healthcare provider before starting ponatinib hydrochloride. Alcohol and certain foods may also affect how this medication works.

References

Frequently Asked Questions

ICLUSIG 15 MG tablets are used to treat certain types of leukemia and other cancers, particularly in patients who have not responded to other treatments.

ICLUSIG 15 MG tablets are taken orally, typically once daily. Follow the instructions provided by your healthcare provider for the best results.

Common side effects may include fatigue, rash, abdominal pain, and changes in blood cell counts. Always consult a healthcare provider for personalized advice.

ICLUSIG 15 MG may interact with other medications. Discuss all current medications with your healthcare provider to avoid potential interactions.

ICLUSIG 15 MG tablets can be purchased from authorized online pharmacies. Ensure you are buying from a reputable source.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.